Increased circulating betatrophin concentrations in patients with type 2 diabetes. - Wikidata - wikimedia - TriplyDB

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q33746462

about

The Relationship between Betatrophin Levels in Blood and T2DM: A Systematic Review and Meta-Analysis The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking The Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer of β-Cell Proliferation Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome.Insulin upregulates betatrophin expression via PI3K/Akt pathway A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase.Emerging regulation and function of betatrophin Associations of betatrophin levels with irisin in Chinese women with normal glucose tolerance.Increased Maternal and Cord Blood Betatrophin in Gestational Diabetes Circulating Betatrophin Correlates with Triglycerides and Postprandial Glucose among Different Glucose Tolerance Statuses--A Case-Control Study Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans.Circulating ANGPTL8/Betatrophin Is Increased in Obesity and Reduced after Exercise Training.Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects.Increased Cord Blood Betatrophin Levels in the Offspring of Mothers with Gestational Diabetes.Plasma betatrophin levels in patients with liver cirrhosis Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.Renal function is independently associated with circulating betatrophin.Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis.Circulating Betatrophin Levels Are Associated with the Lipid Profile in Type 2 Diabetes Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function Betatrophin Acts as a Diagnostic Biomarker in Type 2 Diabetes Mellitus and Is Negatively Associated with HDL-Cholesterol Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome ANGPTL8/Betatrophin R59W variant is associated with higher glucose level in non-diabetic Arabs living in Kuwaits.Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism.The Effects of Serum ANGPTL8/betatrophin on the Risk of Developing the Metabolic Syndrome - A Prospective Study.Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.Increased serum levels of betatrophin in pancreatic cancer-associated diabetes Trans-ancestry Fine Mapping and Molecular Assays Identify Regulatory Variants at the ANGPTL8 HDL-C GWAS Locus.Diabetes mellitus in patients with cirrhosis: clinical implications and management.ANGPTL8 (betatrophin) role in diabetes and metabolic diseases.Betatrophin: no relation to glucose metabolism or weight status in obese children before and after lifestyle intervention.Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes.Increased Serum ANGPTL8 Concentrations in Patients with Prediabetes and Type 2 Diabetes Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance.Circulating betatrophin is associated with insulin resistance in humans: cross-sectional and interventional studies in vivo and in vitro.Serum Betatrophin Concentrations and the Risk of Incident Diabetes: A Nested Case-Control Study from Chungju Metabolic Disease Cohort.Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.

P2860

Q26744764-2F6C4C48-4CC8-494C-9213-355F23657C5C Q26751057-1517B87E-6DC4-4F60-9412-63F1BD102EB6 Q28067572-708C42D8-331C-48B3-9A1A-150926F914BE Q33566553-1D4EFEB5-9264-445E-ABCA-0568296BC5C0 Q33912235-0471D74A-4C93-4E1F-BA0A-B0BF1D20850F Q34234192-EB4696BB-DE9B-4331-881F-F14CFBA6FD4D Q34505898-7421241C-DD78-453E-9145-ED39B6C60BD8 Q34835947-82F7B87B-DC6A-42B6-B550-3A425DA6DD4D Q35344631-936D4370-00FD-4D12-8702-7F7EAC536A32 Q35675901-CCC28B62-0AA9-4A24-A7FB-E85ADC6069B2 Q35738788-53EFDA80-45CD-432A-89C6-0C8F56BC525C Q35803552-D47AA20C-B3D7-4722-9E58-263AA64BFF07 Q35897556-5A49B754-8DFF-4F40-AF2E-CBCD943B2737 Q35986455-5F4B80E7-8581-428D-9B32-5BE1ECE68A3F Q36022397-5ACDC618-886D-4DA4-838E-DA2E30CFFDA5 Q36105642-23C8B1BD-5D0E-43EA-9E8A-7BCC5B95A941 Q36293484-0992E50D-15DC-45ED-B2BB-33D71DE7CC67 Q36296625-F6DF34F6-4810-4B66-B335-9385AC1840A5 Q36329040-E1C7E1D2-5816-470E-A97D-AF8C86A297BD Q36369092-1D77474D-F101-4214-9A74-FD6768CD6A20 Q36419138-6ED34AAA-79F9-4745-8D42-D0C6E8365CDC Q36439716-64386246-182A-43C6-9C33-B7D92910D6BE Q36447052-76347012-BD7E-44AC-88D5-E293B9912561 Q36549866-D6488C75-C751-4949-B5E1-CD82E72A9E28 Q36570704-C72405EE-3A8B-48AF-9926-2AA057B5EA1A Q36764959-2A677771-266F-45BB-A573-C4DA98CCFBE3 Q36885804-734A95A7-4DBF-42D6-B912-13DB5EC77CE6 Q37039907-3208E090-0785-40C7-BC08-108DA4BAFA9E Q37319550-91AE9F20-945C-492A-926D-B511C1EB3978 Q37520539-228E5FA3-BE1E-4135-B5C0-6F11E012365B Q38654366-E3292037-036B-48D5-B814-C83D6330319E Q38773241-CEAFD15E-E4FA-49F7-AD95-1681917A7BCD Q39444032-CA6B3307-AF81-4513-8112-B0D635B66CD2 Q39611756-4C9AAC5D-E500-40E7-BECE-C46671927948 Q41258231-EDA2E6C0-0292-4EE0-8954-CBD939E620B3 Q42730691-9968ADFE-E0E4-4768-87C7-60D94E349016 Q45392774-FEFA2DD3-CC78-4402-A26A-84B46270612A Q47108186-FAE6053B-28EF-4161-8F63-FB6F869BEC25 Q48189444-0B2FFDCF-9D8A-4B53-8B7D-5AEA200C1CF0 Q50936046-90D48801-E656-4FE5-8780-EB5157284576

P2860

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q33746462

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

@ast

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

@en

type

label

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

@ast

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

@en

prefLabel

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

@ast

Increased circulating betatrophin concentrations in patients with type 2 diabetes.

@en

P1433

Q33746462-F5B73CE0-557A-4A15-8615-E4AF9E48FAE0

P1476

Q33746462-09780C22-9A97-4C5C-89EC-D224AA432726

P2093

Q33746462-37D6B993-060B-492C-87FF-96CF8D1FF671

Q33746462-F098FB09-BA7A-4204-BC3D-9631850C5430

Q33746462-F91BA8F7-5221-45AC-8DE3-6B7A2C4109F2

P2860

Q33746462-14CB3BB2-D41E-40BF-902C-05024966D6B7

Q33746462-19CB8BED-E236-40EB-8336-148946A7B36A

Q33746462-40A0E4D3-A7A1-4CBA-BA15-0190F60E905A

Q33746462-431C02A2-EFEC-4003-986B-84A7F338A66F

Q33746462-5959ACE8-8640-464E-B91F-D32D364C06BD

Q33746462-7B41EEE2-A84B-48A2-BE4B-0B3B1F9AAA00

Q33746462-88B8D035-1D5E-4E07-AB0B-6386BD758C60

Q33746462-8D0A92AF-9BAF-46B5-AAC2-CBFF9A88FBC3

Q33746462-AC4B7958-A94E-45B5-8F7B-B44217E72576

Q33746462-AC7E5BE2-35F0-4A17-A5DB-9700191E150B

P304

Q33746462-AA5225B2-70D4-491E-B4F4-BF22420F4B76

P31

Q33746462-6E883BF3-518D-46A8-980C-34F15D450F94

P356

Q33746462-FEE51608-4F39-4EC3-8ADD-7F61E2024189

P478

Q33746462-C05E94FD-4BE7-42CA-89FD-9C5B40EACE46

P50

Q33746462-0F7BC9FA-41C4-4F41-9D64-08B946563CEC

Q33746462-15DBFFA0-339F-4801-AAF5-FB3BE0750655

Q33746462-8EB4E101-61CB-443A-8466-4A0853E4DFA6

P577

Q33746462-F705096D-0CDB-4284-91CC-29EE5F2D9368

P5875

Q33746462-3E5E75E8-3A0C-4E14-AF83-62F7FC2F3EA0

P698

Q33746462-1FE85AEC-320B-4974-940C-F0BA08758270

P921

Q33746462-14683C53-ADA6-48D5-9840-5C3DE043D023

P932

Q33746462-4AA613D0-95F7-464D-96D6-56B73491F474

P356

P1433

International journal of endocrinology

P1476

Increased circulating betatrophin concentrations in patients with type 2 diabetes

@en

P2093

Daniel Espes

http://www.w3.org/2001/XMLSchema#string

Mats Martinell

http://www.w3.org/2001/XMLSchema#string

Per-Ola Carlsson

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Atypical angiopoietin-like protein that regulates ANGPTL3

RETRACTED: Betatrophin: a hormone that controls pancreatic β cell proliferation

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism

Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels

Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. Study.

The association between IGF-I and insulin resistance: a general population study in Danish adults

P304

323407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/323407

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Per-Ola Carlsson

P577

2014-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263432214

http://www.w3.org/2001/XMLSchema#string

P698

24963292

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4055101

http://www.w3.org/2001/XMLSchema#string